Ticker Scorecard - MRKR Basics Company: Marker Therapeutics, Inc. IPO Date: August 1, 2002 Sector: Healthcare Industry: Biotech Market Cap: $16.81M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 4.29% Avg Daily Range (30 D): $0.12 | 5.75% Avg Daily Range (90 D): $0.20 | 6.23% Institutional Daily Volume Avg Daily Volume: .08M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .05M Trade Size Avg Trade Size (Sh.): 55 Avg Trade Size (Sh.) (30 D): 203 Avg Trade Size (Sh.) (90 D): 161 Institutional Trades Total Inst.Trades: 23 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.02M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 106.23K     News Nov 26, 2024 @ 4:00 PM Marker Therapeutics to Present at the Citizens JMP... Source: N/A May 15, 2024 @ 8:15 PM Marker Therapeutics Reports First Quarter 2024 Fin... Source: Marker Therapeutics Apr 8, 2024 @ 11:00 AM Principal Investigator from City of Hope National ... Source: Marker Therapeutics Mar 25, 2024 @ 9:45 PM Marker Therapeutics Reports Year-End 2023 Corporat... Source: Marker Therapeutics Mar 22, 2024 @ 4:30 PM Marker Therapeutics to Present at the H.C. Wainwri... Source: Marker Therapeutics Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.26 $-.25 $-.27 Diluted EPS $-.26 $-.25 $-.27 Revenue $ 1.93M $ 1.17M $ 1.24M Gross Profit $ $ $ Net Income / Loss $ -2.31M $ -2.19M $ -2.39M Operating Income / Loss $ -2.4M $ -2.31M $ -2.55M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Jan 27, 2023:   10:1 Sep 16, 2016:   12:1 Feb 25, 2014:   100:1 Jul 27, 2009:   10:1 Jun 28, 2007:   5:2 Jun 08, 2001:   50:1